Debevoise Advises Deutsche Bank as Financial Advisor to Mallinckrodt in the $1.2 Billion Acquisition of Sucampo Pharmaceuticals
Debevoise Advises Deutsche Bank as Financial Advisor to Mallinckrodt in the $1.2 Billion Acquisition of Sucampo Pharmaceuticals
Debevoise & Plimpton LLP is advising Deutsche Bank as financial advisor to Mallinckrodt plc in the $1.2 billion acquisition of Sucampo Pharmaceuticals, Inc.
The Debevoise team is led by partner Andrew L. Bab and includes associates Giselle Alvarado and Claire Hansen Suni.